ATE213268T1 - FANCONI GEN II - Google Patents

FANCONI GEN II

Info

Publication number
ATE213268T1
ATE213268T1 AT98921434T AT98921434T ATE213268T1 AT E213268 T1 ATE213268 T1 AT E213268T1 AT 98921434 T AT98921434 T AT 98921434T AT 98921434 T AT98921434 T AT 98921434T AT E213268 T1 ATE213268 T1 AT E213268T1
Authority
AT
Austria
Prior art keywords
fanconi
polypeptide
gen
antibody
nucleic acid
Prior art date
Application number
AT98921434T
Other languages
German (de)
Inventor
Manfred Kubbies
Andreas Machl
Simone Planitzer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Priority claimed from PCT/EP1998/001994 external-priority patent/WO1998045428A1/en
Application granted granted Critical
Publication of ATE213268T1 publication Critical patent/ATE213268T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Abstract

The present invention concerns a pathophysiologically relevant gene associated with Fanconi anaemia (FA), a polypeptide coded thereby, an antibody directed against the polypeptide as well as the pharmaceutical applications of the nucleic acid, polypeptide and antibody.
AT98921434T 1997-04-07 1998-04-06 FANCONI GEN II ATE213268T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97105688 1997-04-07
PCT/EP1998/001994 WO1998045428A1 (en) 1997-04-07 1998-04-06 Fanconi-gen ii

Publications (1)

Publication Number Publication Date
ATE213268T1 true ATE213268T1 (en) 2002-02-15

Family

ID=8226668

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921434T ATE213268T1 (en) 1997-04-07 1998-04-06 FANCONI GEN II

Country Status (5)

Country Link
JP (1) JP2000510002A (en)
AT (1) ATE213268T1 (en)
AU (1) AU723543B2 (en)
CA (1) CA2285605A1 (en)
DE (1) DE59803082D1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4461179B2 (en) 2005-02-25 2010-05-12 オンコセラピー・サイエンス株式会社 Peptide vaccine against lung cancer expressing TTK, URLC10, or KOC1 polypeptide

Also Published As

Publication number Publication date
AU7429398A (en) 1998-10-30
AU723543B2 (en) 2000-08-31
CA2285605A1 (en) 1998-10-15
DE59803082D1 (en) 2002-03-21
JP2000510002A (en) 2000-08-08

Similar Documents

Publication Publication Date Title
ATE348178T1 (en) ACTIVAtable RECOMBINANT NEUROTOXINS
ATE317441T1 (en) CATHEPSIN-02 PROTEASE
ATE394484T1 (en) SMAD 6 AND ITS APPLICATIONS
ATE454393T1 (en) EGVII-ENDOGLUCANASE AND NUCLEIC ACIDS CODING THEREOF
DE69931507D1 (en) INTERFERON-BETA FUSION PROTEINS AND ITS USES
CA2160131A1 (en) New Bacillus Thuringiensis Strains and Their Insecticidal Proteins
WO2001064834A8 (en) Novel nucleic acids and polypeptides
AU1113999A (en) Target sequences for synthetic molecules and methods of using same
FR2710195B1 (en) Antenna-electronic circuit assembly.
ATE253113T1 (en) NUCLEIC ACID ENCODING A FIBROBLAST ACTIVATION PROTEIN AND USES THEREOF
DE69736975D1 (en) ENZYM WITH GALACTANASE ACTIVITY
DE69634077D1 (en) HAEMOPHILUS ADHESION PROTEINS
ATE213268T1 (en) FANCONI GEN II
DE69838810D1 (en) GENE OF ALTEROMONAS
AU8405798A (en) A swine hepatitis e virus and uses thereof
AU1818399A (en) Novel flea epoxide hydrolase nucleic acid molecules, proteins and uses thereof
EP0846165A4 (en) Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
FR2703124B1 (en) ELASTICALLY DEFORMABLE BELLOWS.
DK43393D0 (en) DNA sequence encoding an enzyme
DK1196607T3 (en) Antibacterial chlamysin B protein, gene coding therefore as well as expression system
SE0101519D0 (en) Nucleic ACID
ITRM950434A0 (en) POLYPEPTIDE FOR THE REPAIR OF GENETIC INFORMATION, NUCLEOTIDE SEQUENCE THAT CODES FOR IT AND PROCEDURE FOR ITS PREPARATION.
SE9302856D0 (en) Method and means for producing a plasma protein binding protein
BR7300976U (en) Gas request form.
ITVT930003A0 (en) AXIAL COMPRESSOR (AXIAL LOADER).

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee